Efficiency of Speech and Language Intervention on Achievement of Children With Developmental Language Disorder

Therapy Clinical Trial

— DYSPHADEV  

Official title:

Efficiency of Speech and Language Intervention on Achievement of Children With Developmental Language Disorder

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04926311
• Other study ID #: PI2018_843_0052
• Status: Completed
• Start date: June 8, 2021
• Est. completion date: June 1, 2022

Study information

• Verified date: January 2023
• Source: Centre Hospitalier Universitaire, Amiens
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Children with Developmental Language Disorder (DLD) have many linguistic difficulties in syntax, lexicon, morphology and phonology. Frequently, they also present co-occurrent (or comorbidities) impairments which further impaired school learning. Thus, they have poor academic outcomes and many of these children have been maintained at least one time in a classroom, sometime more.

The purpose of this project is to determine which modalities of speech and language therapy are the more efficient on academic outcomes of children with DLD. The main modalities that will be studied are the duration of speech and language intervention, the age at which begins the intervention and the intensity (number of intervention sessions per week).

Recruitment information / eligibility

• Status: Completed
• Enrollment: 130
• Est. completion date: June 1, 2022
• Est. primary completion date: June 1, 2022
• Accepts healthy volunteers: No
• Gender: All
• Age group: 12 Years and older

Eligibility

Inclusion Criteria:

• patients Have been diagnosed in the University Hospital of Amiens-Picardie with a Developmental Language Disorder

• patients must be aged 12 or older,

• patients must be agreed answering the questionnaire

Exclusion Criteria:

• Children with a neurological pathology or handicap as epilepsy, cerebral palsy, sequelae of severe brain injury (traumatic or ischemic or inflammatory...)

• patients with a severe mental retardation

• patients with autism

• patients with bipolar illness

• patients with psychosis

Related Conditions & MeSH terms

• Disease
• Language Development Disorders
• Language Disorders
• Speech and Language Disorder
• Therapy

Locations

Country	Name	City	State
France	CHU Amiens	Amiens

Sponsors (1)

Lead Sponsor	Collaborator
Centre Hospitalier Universitaire, Amiens

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Number of repeated school year according length of language therapy (number of days)	Number of repeated school year according length of language therapy	one day